Anavex Life Sciences Corp (AVXL)

[Doc328]

Therefore yes blarca a little more bad but clearly dropouts are normal

Actual numbers, rather than ones you made up, can be seen in the JPAD paper
https://pubmed.ncbi.nlm.nih.gov/39800452/

Blarcamesine dropout
202/335 treated patients completed 48 weeks = 60% (40% dropout)
------- 54% dropout in 50 mg dose and 67% dropout in 30 mg dose
136/168 placebo patients completed 48 weeks = 81% (19% dropout)

This huge dropout was over 48 weeks, MAbs were over 72. Details do matter